6CM
IMVTW

683 Capital Management’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

683 Capital Management’s Portfolio IMVTW Stock Details IMVTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-253,600
Closed -$609K – 165
2020
Q1 		$609K Sell
253,600
-24,658
-9% -$47.4K 0.07% 99
2019
Q4 		$557K Buy
+278,258
New +$563K 0.06% 80

683 Capital Management's IMVTW Position: Q2 2020 in Review

683 Capital Management sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 253,600 shares — an estimated $609K sold.

683 Capital Management first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $609K in Q1 2020. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

  • 683 Capital Management reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
  • 683 Capital Management sold 253,600 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $609K.
  • 683 Capital Management first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
  • 683 Capital Management's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $609K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on 683 Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.